logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

BEAUTYFARM MED (02373) purchased approximately 4.75 million shares for about 862,800 Hong Kong dollars on June 12th.

date
20:43 12/06/2026
avatar
GMT Eight
Beautiful Countryside Health (02373) announced that on June 12, 2026, approximately HK$862,800 was spent to repurchase 47,500 shares.
BEAUTYFARM MED (02373) announced that on June 12, 2026, it bought back approximately 47,500 shares at a cost of about 862,800 Hong Kong dollars.
Related Articles
HK Stock
YUK WING GP (01536) intends to acquire 65% equity of Anhui Runsheng Electric Power Technology for 37.5 million yuan.
US Stock
SharonAI (SHAZ.US) signs a six-year computing power collaboration agreement with NVIDIA Corporation to advance the expansion of AI data centers in Australia.
YingEn Biotech (09606) has submitted its IPO application to the Shanghai Stock Exchange Science and Technology Innovation Board, deeply focusing on the field of Antibody Drug Conjugates (ADC).
YUK WING GP (01536) intends to acquire 65% equity of Anhui Runsheng Electric Power Technology for 37.5 million yuan.
HK Stock
SharonAI (SHAZ.US) signs a six-year computing power collaboration agreement with NVIDIA Corporation to advance the expansion of AI data centers in Australia.
US Stock
YingEn Biotech (09606) has submitted its IPO application to the Shanghai Stock Exchange Science and Technology Innovation Board, deeply focusing on the field of Antibody Drug Conjugates (ADC).
RECOMMEND
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.